Thursday, March 9 at 12 PM Central
Dr. Adam Murphy will summarize the results of a randomized controlled trial assessing the impact of a Genomic Assay on urologists and patients treatment preferences for favorable risk. prostate cancer.
Adam B. Murphy, MD, MBA, MSCI
Assitant Professor of Urology & Preventive Medicine
Northwestern University Feinberg School of Medicine
For more public health news, events, and announcements, visit the IPHAM website: https://feinberg.northwestern.edu/ipham